Pharmacodynamics of Cinacalcet Over 48 Hours in Patients With Controlled Secondary Hyperparathyroidism: Useful Data in Clinical Practice-Reference-Cited by-同舟云学术

Pharmacodynamics of Cinacalcet Over 48 Hours in Patients With Controlled Secondary Hyperparathyroidism: Useful Data in Clinical Practice

Published:2013-04-01 Issue:4 Volume:98 Page:1718-1725
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Arenas M. Dolores¹,de la Fuente Vanesa¹,Delgado Pablo¹,Gil María Teresa¹,Gutiérrez Patricia¹,Ribero Jorge¹,Rodríguez Mariano²,Almadén Yolanda³

Affiliation:

1. Nephrology Service (M.D.A., V.d.l.F., P.D., M.T.G., P.G., J.R.), Hospital Perpetuo Socorro, ES-03013 Alicante, Spain

2. Nephrology Service (M.R.), Hospital Reina Sofía, ES-14004 Córdoba, Spain

3. Lipid and Atherosclerosis Unit (Y.A.), IMIBIC/Reina Sofia University Hospital/University of Cordoba, and Centro de Investigación Biomédica en Red Fisiopatologia Obesidad y Nutricion, Instituto de Salud Carlos III, ES-28029 Madrid, Spain

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/98/4/1718/9048524/jcem1718.pdf

Reference40 articles.

1. Calcification and cardiovascular health: new insights into an old phenomenon;Ketteler;Hypertension,2006

2. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease;Blacher;Hypertension,2001

3. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management;Block;Am J Kidney Dis,2000

4. Consistent control of mineral and bone disorder in incident hemodialysis patients;Danese;Clin J Am Soc Nephrol,2008

5. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients;Ganesh;J Am Soc Nephrol,2001

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular medicinal insights into scaffold hopping-based drug discovery success;Drug Discovery Today;2024-01

2. Discovery of LNP1892: A Precision Calcimimetic for the Treatment of Secondary Hyperparathyroidism;Journal of Medicinal Chemistry;2023-07-13

3. AC-265347 Inhibits Neuroblastoma Tumor Growth by Induction of Differentiation without Causing Hypocalcemia;International Journal of Molecular Sciences;2022-04-13

4. Cortical porosity development and progression is mitigated after etelcalcetide treatment in an animal model of chronic kidney disease;Bone;2022-04

5. The Effectiveness of Alternate-day Cinacalcet Therapy for Secondary Hyperparathyroidism in Noncompliant Hemodialysis Patients;Saudi Journal of Kidney Diseases and Transplantation;2022